科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/13 | 5,550 | 5,560 | 5,330 | 5,400 | -60 | -1.1% | 114,900 |
2019/02/12 | 5,370 | 5,480 | 5,370 | 5,460 | +160 | +3% | 75,300 |
2019/02/08 | 5,320 | 5,350 | 5,270 | 5,300 | -100 | -1.9% | 85,000 |
2019/02/07 | 5,400 | 5,490 | 5,340 | 5,400 | -20 | -0.4% | 80,600 |
2019/02/06 | 5,350 | 5,490 | 5,350 | 5,420 | +40 | +0.7% | 76,200 |
2019/02/05 | 5,460 | 5,470 | 5,360 | 5,380 | -20 | -0.4% | 67,000 |
2019/02/04 | 5,190 | 5,440 | 5,190 | 5,400 | +140 | +2.7% | 119,600 |
2019/02/01 | 5,150 | 5,280 | 5,140 | 5,260 | +130 | +2.5% | 99,800 |
2019/01/31 | 5,180 | 5,210 | 5,110 | 5,130 | -40 | -0.8% | 90,700 |
2019/01/30 | 5,180 | 5,200 | 5,110 | 5,170 | ±0 | ±0% | 95,400 |
2019/01/29 | 5,070 | 5,180 | 5,060 | 5,170 | +80 | +1.6% | 112,300 |
2019/01/28 | 5,150 | 5,170 | 5,080 | 5,090 | -80 | -1.5% | 64,400 |
2019/01/25 | 5,150 | 5,190 | 5,120 | 5,170 | -10 | -0.2% | 134,200 |
2019/01/24 | 5,180 | 5,200 | 5,140 | 5,180 | -40 | -0.8% | 91,600 |
2019/01/23 | 5,200 | 5,240 | 5,160 | 5,220 | -70 | -1.3% | 86,100 |
2019/01/22 | 5,350 | 5,350 | 5,260 | 5,290 | -10 | -0.2% | 43,000 |
2019/01/21 | 5,310 | 5,340 | 5,300 | 5,300 | ±0 | ±0% | 59,700 |
2019/01/18 | 5,340 | 5,370 | 5,300 | 5,300 | -30 | -0.6% | 66,600 |
2019/01/17 | 5,280 | 5,330 | 5,250 | 5,330 | +90 | +1.7% | 87,800 |
2019/01/16 | 5,310 | 5,320 | 5,240 | 5,240 | -30 | -0.6% | 66,100 |
2019/01/15 | 5,180 | 5,280 | 5,150 | 5,270 | +40 | +0.8% | 93,700 |
2019/01/11 | 5,310 | 5,320 | 5,200 | 5,230 | -30 | -0.6% | 94,900 |
2019/01/10 | 5,140 | 5,270 | 5,140 | 5,260 | +20 | +0.4% | 154,800 |
2019/01/09 | 5,120 | 5,280 | 5,090 | 5,240 | +220 | +4.4% | 171,800 |
2019/01/08 | 5,050 | 5,100 | 4,990 | 5,020 | -130 | -2.5% | 184,800 |
2019/01/07 | 5,120 | 5,210 | 5,100 | 5,150 | +175 | +3.5% | 170,400 |
2019/01/04 | 4,795 | 4,980 | 4,780 | 4,975 | +110 | +2.3% | 170,800 |
2018/12/28 | 4,905 | 4,945 | 4,860 | 4,865 | -110 | -2.2% | 125,400 |
2018/12/27 | 4,860 | 4,990 | 4,860 | 4,975 | +210 | +4.4% | 138,100 |
2018/12/26 | 4,670 | 4,790 | 4,670 | 4,765 | +210 | +4.6% | 154,500 |
2018/12/25 | 4,640 | 4,640 | 4,535 | 4,555 | -295 | -6.1% | 135,300 |
2018/12/21 | 4,870 | 4,900 | 4,825 | 4,850 | -90 | -1.8% | 181,400 |
2018/12/20 | 4,980 | 5,070 | 4,910 | 4,940 | -140 | -2.8% | 205,800 |
2018/12/19 | 5,100 | 5,100 | 5,040 | 5,080 | -90 | -1.7% | 126,700 |
2018/12/18 | 5,250 | 5,250 | 5,170 | 5,170 | -130 | -2.5% | 97,100 |
2018/12/17 | 5,330 | 5,340 | 5,270 | 5,300 | -90 | -1.7% | 96,200 |
2018/12/14 | 5,350 | 5,450 | 5,350 | 5,390 | -20 | -0.4% | 135,800 |
2018/12/13 | 5,390 | 5,460 | 5,370 | 5,410 | +80 | +1.5% | 116,700 |
2018/12/12 | 5,310 | 5,360 | 5,260 | 5,330 | +110 | +2.1% | 133,000 |
2018/12/11 | 5,340 | 5,370 | 5,200 | 5,220 | -110 | -2.1% | 116,400 |
2018/12/10 | 5,320 | 5,370 | 5,290 | 5,330 | -150 | -2.7% | 119,700 |
2018/12/07 | 5,390 | 5,490 | 5,340 | 5,480 | +130 | +2.4% | 165,400 |
2018/12/06 | 5,460 | 5,480 | 5,330 | 5,350 | -160 | -2.9% | 155,100 |
2018/12/05 | 5,530 | 5,550 | 5,490 | 5,510 | -110 | -2% | 156,500 |
2018/12/04 | 5,790 | 5,830 | 5,600 | 5,620 | -210 | -3.6% | 160,000 |
2018/12/03 | 5,890 | 5,930 | 5,810 | 5,830 | +20 | +0.3% | 105,900 |
2018/11/30 | 5,750 | 5,830 | 5,740 | 5,810 | +60 | +1% | 112,200 |
2018/11/29 | 5,780 | 5,840 | 5,730 | 5,750 | +40 | +0.7% | 96,700 |
2018/11/28 | 5,620 | 5,730 | 5,600 | 5,710 | +100 | +1.8% | 81,900 |
2018/11/27 | 5,590 | 5,660 | 5,580 | 5,610 | +30 | +0.5% | 84,000 |
1551~
1600
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム